Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Can the biopharma sector retain the investing momentum it saw in 2020 as generalists turned their attention to the space?
After a monumental year for biopharma investment in 2020, how much of that momentum can the sector carry over into the new year? Market watchers are beginning to place their bets.
This year, the annual Biotech Showcase event went digital in the face of the global COVID-19 pandemic, with experts in the space meeting online to share the latest insider information with investors.
One immediately recognizable trend was how much of a push the biopharma industry has experienced thanks to a growing appetite from generalist investors. This was in large part due to the attention that drug development received last year it led to a rush of initial public offerings (IPOs) and to the emergence of special purpose acquisition companies (SPACs) in the space.